Skip to main content

Natures Sunshine Products Inc

NATR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000275053

In the last 90 days, Natures Sunshine Products Inc insiders filed 2 open-market purchases and 0 sales; 153 institutions reported holding it in 13F filings for Q2 2026, worth $343.6M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Natures Sunshine Products Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of NATR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8381−2
Shares14.5M14.5M−57.2K (−0.4%)
Value$154.8M$119.1M−$35.7M (−23.1%)

New holders (6)

Institutions that held Natures Sunshine Products Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to NATR in Q3 2022
InstitutionSharesValue% of portfolio
Ameriprise Financial Inc58,470$483.0K0.00%
O'Shaughnessy Asset Management, LLC12,218$101.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.10,142$84.0K0.00%
Gladius Capital Management LP4,044$34.0K0.01%
Covestor Ltd413$3.00K0.00%
Glassman Wealth Services90$1.00K0.00%

Sold out (8)

Institutions that held Natures Sunshine Products Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of NATR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Rice Hall James & Associates, LLC227,471$2.43M
Oppenheimer Asset Management Inc.21,202$226.0K
Globeflex Capital L P19,796$211.0K
Susquehanna International Group, LLP14,543$155.0K
DuPont Capital Management Corp12,406$132.0K
Lazard Asset Management LLC4,795$51.0K
Captrust Financial Advisors89$1.00K
Advisor Group Holdings, Inc.10$0